Trial Radar AI | ||
|---|---|---|
Clinical Trial NCT07392762 (V-RECS) for Shoulder Pain, Chronic Shoulder Pain, Musculoskeletal Shoulder Pain is not yet recruiting. See the Trial Radar Card View and AI discovery tools for all the details. Or ask anything here. | ||
One study matched filter criteria
Card View
Virtual Reality-Supported Exercise for Chronic Musculoskeletal Shoulder Disorders: a Feasibility Study (V-RECS) 20 Exercise-Based Virtual
Clinical Trial NCT07392762 (V-RECS) is an interventional study for Shoulder Pain, Chronic Shoulder Pain, Musculoskeletal Shoulder Pain and is currently not yet recruiting. Enrollment is planned to begin on 16 January 2026 and continue until the study accrues 20 participants. Led by Royal National Orthopaedic Hospital NHS Trust, this study is expected to complete by 1 December 2026. The latest data from ClinicalTrials.gov was last updated on 6 February 2026.
Brief Summary
People with long-term (chronic) shoulder disorders caused by injuries, overuse or conditions (such as arthritis) often need physiotherapy. This usually includes exercise therapy to help reduce pain, rebuild strength and make every day activities easier. However, it can be hard to stick to an exercise programme. People may stop due to pain, fear of making the symptoms worse or simply loosing motivation.
Virtual Reali...
Show MoreDetailed Description
Chronic shoulder disorders are long-lasting problems that cause pain, stiffness, or weakness in the shoulder. 'Chronic' means the condition has lasted for more than three months. These issues can make everyday tasks like reaching, lifting, or getting dressed, painful and difficult. Chronic shoulder disorders are very common. They affect people of all ages, but are more likely to occur in adults over 40. It is estimat...Show More
Official Title
Virtual Reality-Supported Exercise for Chronic Musculoskeletal Shoulder Disorders: a Feasibility Study (The V-RECS Study)
Conditions
Shoulder PainChronic Shoulder PainMusculoskeletal Shoulder PainOther Study IDs
- V-RECS
- 359174
NCT ID Number
Start Date (Actual)
2026-01-16
Last Update Posted
2026-02-06
Completion Date (Estimated)
2026-12
Enrollment (Estimated)
20
Study Type
Interventional
PHASE
N/A
Status
Not yet recruiting
Keywords
Virtual Reality
VR
Musculoskeletal Rehabilitation
Musculoskeletal Shoulder Pain
Chronic Shoulder Pain
Shoulder pain disorders
VR
Musculoskeletal Rehabilitation
Musculoskeletal Shoulder Pain
Chronic Shoulder Pain
Shoulder pain disorders
Primary Purpose
Treatment
Design Allocation
N/A
Interventional Model
Single Group
Masking
None (Open Label)
Arms / Interventions
| Participant Group/Arm | Intervention/Treatment |
|---|---|
ExperimentalVirtual Reality Exercise Programme Consenting participants will attend three VR exercise sessions delivered by an upper limb physiotherapist at the Royal National Orthopaedic Hospital (RNOH), using the SyncVR FIT platform.
The SyncVR FIT platform is designed to support unilateral or bilateral upper limb movement through a series of interactive games, tasks, and challenges delivered via a VR headset. Participants will use handheld controllers to engag...Show More | Virtual Reality Participants will engage with a 30 minute shoulder exercise programme using the SyncVR platform. There will be three intervention sessions in total and they will be spaced out once per week for a period of three weeks. |
Primary Outcome Measures
Secondary Outcome Measures
| Outcome Measure | Measure Description | Time Frame |
|---|---|---|
Consent rate | The consent rate will be used as a measure of recruitment and will be defined as the number of participants who provide informed consent divided by the total number of patients screened for eligibility, ie: number of people who consented/number of people approached) x 100. | During enrolment period |
Dropout rate | The dropout rate will be defined as the percentage of participants who started the study, but did not complete all three treatment visits. | From first treatment visit though completion of treatment (average of 3 weeks) |
| Outcome Measure | Measure Description | Time Frame |
|---|---|---|
Pain Intensity - Numeric Pain Rating Scale (NPRS) | The NPRS is a validated, 11-item unidimensional numerical rating scale, with 0 representing 'no pain' and 10 representing 'worst imaginable pain' in the past 24 hours. | * Baseline (Pre-intervention), * Immediately before and after each treatment session (up to 3 visits), * One follow-up 1 visit (within 48 hours of the last treatment session, average of 3 weeks) |
Shoulder Range of Movement | Shoulder ROM will be measured using a validated self-assessment questionnaire published by Yang et al 2015. | Baseline (pre-intervention) and at follow-up 1(within in 48 hours of final treatment session, average of 3 weeks). |
Disability - Shoulder Pain and Disability Index (SPADI) | The SPADI is a validated, self-administered questionnaire involving two dimensions (pain and functional activities) and 13 items. Scores can range between 0-100, where higher scores indicate worsening disability. | Baseline (pre-intervention) and at follow-up 1(within in 48 hours of final treatment session, average of 3 weeks). |
Quality of Life - EuroQol- 5 Dimension (EQ-5D-3L) | The EQ-5D-5L is a widely used, validated measure of health-related quality of life in terms of 5 dimensions (mobility, ability to self-care, ability to undertake usual activities, pain and discomfort, anxiety and depression), each with 5 levels of severity. | Baseline (pre-intervention) and at follow-up 1(within in 48 hours of final treatment session, average of 3 weeks). |
Sleep Quality - Pittsburgh Sleep Quality Index (PSQI) | The PSQI is a validated, self-reported questionnaire evaluating key areas including sleep duration, latency (how long it takes to fall asleep), efficiency, disturbances, use of sleep medication and day time dysfunction. Each section is scored individually, then added up to generate a global score ranging between 0-21. A score higher than 5 indicative of poor quality of sleep. | Baseline (pre-intervention) and at follow-up 1(within in 48 hours of final treatment session, average of 3 weeks). |
Usability - System Usability Scale (SUS) | The SUS is a widely used 10 item questionnaire to measure how usable or user-friendly a system, product or service is. | Follow-up 1(within in 48 hours of final treatment session, average of 3 weeks). |
Satisfaction - Quebec User Evaluation of Satisfaction with assistive Technology (QUEST) | The QUEST questionnaire is a standardised 12-item, validated questionnaire designed to measure how satisfied users are with both their assistive devices and the service the received. | Follow-up 1(within in 48 hours of final treatment session, average of 3 weeks). |
Cybersickness in VR Questionnaire (CSQ-VR). | The CSQ-RV questionnaire will be used to assess symptoms commonly caused by VR exposure, such a nausea and dizziness. | Immediately after treatment visit 1, 2, 3 and at follow-up 1(within in 48 hours of final treatment session, average of 3 weeks). |
Participation Assistant
Eligibility Criteria
Eligible Ages
Adult, Older Adult
Minimum Age
18 Years
Eligible Sexes
All
- Adult patients >18 years with diagnosed unilateral/ bilateral shoulder pain with/ without co-existing symptoms of instability and or stiffness (persisting > three months) generated from a Musculoskeletal origin
- Patients who have been referred for conservative management
- New or follow-up patients
- Sufficient English to understand written materials/verbal instruction/or accompanied by family/friends able to translate
- Patients who provide informed, written consent to enter the study
- Unable to provide informed consent
- On a waiting list for surgery and/or injections
- Referred for post-operative physiotherapy
- Shoulder pain not originating from an MSK aetiology (such as hemiplegia or peripheral nerve injury)
- Active history of seizures
- Other relevant medical conditions deemed inappropriate for patients to participate e.g. visual impairment, unstable psychiatric illnesses.
- Shoulder pain associated with bone metastasis
- Currently taking part in any other upper limb research study
- Patients who do not adequately understand verbal explanations or written information given in English (or are not accompanied by an interpreter/family member).
Royal National Orthopaedic Hospital NHS TrustSyncVR MedicalStudy Central Contact
Contact: Rokhsaneh m Tehrany, PhD, 00447958830304, [email protected]
1 Study Locations in 1 Countries
London
Royal National Orthopaedic Hospital, Middlesex, London, HA74LP, United Kingdom
Rokhsaneh M Tehrany, PhD, Contact, +447958830304, [email protected]
Anju Jaggi, MSc, Contact, 00442089095820, [email protected]